Month: January 2022

RBA to join the rate-rise race?

It’s anyone’s guess how many rises the Fed will see this year, but NAB’s Tapas Strickland says one is expected for Australia, although don’t expect the RBA to admit it today. A sharp end to QE does seem likely though.

Aussie dollar loses break point

Nadal did better last night than the Aussie dollar managed on Friday. On today’s podcast Ray Attrill has a theory why the currency is losing so much ground, even with rising commodity prices.

The aftermath of the Fed

Yield curves have flattened somewhat since the Fed. NAB’s Gavin Friend says although Jerome Powell was hawkish at the press conference, he was also very vague on timings beyond March.

Fed confirms move to post-pandemic policy

The FOMC met and gave the market what it was expecting, says NAB David d e Garis. Although we have still seen a fall in equities and a sharp rise in bond yields. Hear the take-outs from the Jerome Powell press conference in this morning’s podcast

Ukraine fears creates a risk off sell off

Geopolitics has had an influence on markets today, but the influence of the Fed should still not be underestimated says NAB’s Ray Attrill on today’s Morning Call podcast.

Who controls interest?

Interest rates are going up. I ask Steve Keen if it’s a good idea in this environment, and what if you took this key instrument away from central banks and interest rates never changed?

Turnaround in bonds ahead of FOMC this week

Bond yields have fallen slightly. NAB’s Tapas Strickland suggests it might be down to expectation of more moderate language from the Fed as they try and rein in the response to their recent hawkish stance.

Aussie jobs flourish and US equities bounce

Equities rise and bond yields fall. NAB’s David de Garis asks, is it just a bear market bounce? NAB’s Ivan Colhoun looks at the implications of yesterday’s strong Aussie jobs numbers.

Inflation (almost) everywhere

Rising yields in Germany and the UK show the inflation story is not just a US dynamic, says NAB’s Gavin Friend. It’s everywhere.

Markets swallow the post-Omicron outlook pill

Demand for oil is reflecting the view that markets will reopen faster, says NAB’s Rodrigo Catril. Pfizer’s morning-after COVID pill will help with that, but it won’t help with inflation concerns.

Scroll to top